J Physiol Society Meetings
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Physiol Volume 548, Number 1, 121-129, April 1, 2003 DOI: 10.1113/jphysiol.2002.035063
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
548/1/121    most recent
2002.035063v1
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jennings, E. A.
Right arrow Articles by Christie, M. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jennings, E. A.
Right arrow Articles by Christie, M. J.
J Physiol (2003), 548.1, pp. 121-129
© Copyright 2003 D 2003 The Physiological Society
DOI: 10.1113/jphysiol.2002.035063

The actions of anandamide on rat superficial medullary dorsal horn neurons in vitro

E. A. Jennings *, C. W. Vaughan *†, L. A. Roberts * and M. J. Christie *‡

* Department of Pharmacology and ‡ The Medical Foundation, The University of Sydney, NSW 2006 and † Department of Anaesthesia and Pain Management, Royal North Shore Hospital, St Leonards, NSW 2065, Australia

Whole-cell patch-clamp recordings were made from neurons in the trigeminal nucleus caudalis and trigeminal ganglion, in vitro, to investigate the cellular actions of the endogenous cannabinoid, anandamide. Anandamide has been shown to act through both the cannabinoid receptor 1 (CB1) and the vanilloid receptor 1 (VR1). Anandamide (30 µM) caused a 54 % increase in the rate of miniature excitatory post-synaptic currents (mEPSCs), without affecting their amplitude. The effect of anandamide was blocked by the VR1 antagonist capsazepine (20 µM), but not by the CB1-specific antagonist AM251 (3 µM). Application of the VR1 receptor agonist capsaicin (300 nM) caused a 4200 % increase in the mEPSC rate. In dissociated trigeminal ganglion neurons, both anandamide and capsaicin caused an outward current in neurons that were voltage clamped at +40 mV. The maximal outward current produced by anandamide (EC50, 10 µM) was 45 % of that produced by capsaicin (10 µM). Co-application of the VR1 antagonist capsazepine (30 µM) completely reversed the effects of both capsaicin and anandamide. The anandamide transport inhibitor, AM404 (30 µM) caused a 40 % increase in mEPSC rate in the slice preparation and an outward current in dissociated neurons. The latter current was reversed by the VR1 antagonist iodoresiniferatoxin (1 µM). The fatty acid amide hydrolase (FAAH) inhibitors phenylmethylsulfonyl fluoride (PMSF) (20 µM) and OL53 (1 µM) did not enhance the effect of anandamide in either the slice or dissociated neuron preparations. These results suggest that within the superficial medullary dorsal horn, anandamide (30 µM) acts presynaptically to enhance the release of glutamate via activation of the VR1 receptor.



This article has been cited by other articles:


Home page
J. Neurosci.Home page
A. V. Derbenev, M. J. Monroe, N. R. Glatzer, and B. N. Smith
Vanilloid-mediated heterosynaptic facilitation of inhibitory synaptic input to neurons of the rat dorsal motor nucleus of the vagus.
J. Neurosci., September 20, 2006; 26(38): 9666 - 9672.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
K Fujino, S G de la Fuente, Y Takami, T Takahashi, and C R Mantyh
Attenuation of acid induced oesophagitis in VR-1 deficient mice
Gut, January 1, 2006; 55(1): 34 - 40.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
L. S. Premkumar, Z.-H. Qi, J. Van Buren, and M. Raisinghani
Enhancement of Potency and Efficacy of NADA by PKC-Mediated Phosphorylation of Vanilloid Receptor
J Neurophysiol, March 1, 2004; 91(3): 1442 - 1449.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 The Physiological Society.